- recruitingPHASE2
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer
This study is for women with ovarian cancer that has come back, specifically a type that has responded well to chemotherapy in the past. It's looking at a new way to give carboplatin, a common chemotherapy drug, to see if it can work better and with fewer side effects.
United Kingdom - not yet recruitingPHASE3
ICRA Randomised Controlled Trial
This study compares two ways to treat advanced ovarian cancer: surgery after a few chemotherapy cycles (interval surgery) versus surgery after more chemotherapy (delayed surgery). It aims to find out if one approach leads to better survival for women.
United Kingdom